Decipher Prostate Metastatic Genomic Classifier is now available for patients with metastatic prostate cancer.

Artificial intelligence can help urologists and oncologists make treatment recommendations that are objective and evidence-based.

Nearly all men with a polygenic risk score in the 90th percentile or above had a 10-year absolute risk for prostate cancer exceeding 3.8%. A polygenic risk score (PRS) identifies more patients with ...

As many men delay seeing a doctor out of embarrassment, a number of non-invasive tests for prostate and testicular cancer are on the horizon that are even more accurate in detecting the disease in ...

A new spit test for prostate cancer has helped two brothers discover life-threatening tumours that were missed by traditional checks. Dheeresh Turnbull, a cognitive behavioural therapist from Brighton ...

Prostate cancer is the most common cancer in men worldwide. Thanks to scientific breakthroughs, there are more ways than ever to treat it — especially when it’s caught early. One ...

A BBC presenter has shared an emotional update after experiencing the “worst day of his life”. Famous for hosting Good ...

A new study provides the strongest evidence to date on the clinical utility of a polygenic score for prostate cancer ...

“This test could turn the tide on prostate cancer,” said Prof. Ros Eeles, who led the study. “We have shown that a relatively ...